Clearmind Medicine to move forward with MEAI-based alcohol substitute
Clearmind Medicine (CMND) recently announced that it signed a non-binding term sheet with Dr. Glitter Pty Ltd, a health ...
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0 ...
Nasdaq5d
Clearmind Medicine Inc. Partners with Dr. Glitter Pty Ltd for Development of MEAI-Based Alcohol Alternative in ActivCrystal™ Format
Clearmind Medicine Inc. has signed a non-binding term sheet with Dr. Glitter Pty Ltd to collaborate on the development of a proprietary alcohol substitute based on MEAI technology, utilizing Dr ...
Business Insider5d
Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute
Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine ...
Nasdaq5d
Clearmind Medicine to move forward with MEAI-based alcohol substitute
Clearmind Medicine (CMND) recently announced that it signed a non-binding term sheet with Dr. Glitter Pty Ltd, a health technology company that has developed ActivCrystal technology, a world-first ...
Clearmind Medicine Inc.: Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial
Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on discovery and development ...
Mena FN5d
Clearmind Medicine Looks To Move Forward With Its Novel Psychedelic MEAI- Based Alcohol Substitute
“We are thrilled to partner with Dr Glitter to advance the development of MEAI as a safe alternative to alcohol,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.“In parallel to ...